Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2019

01-04-2019 | Letter to the Editor

Should we still collect blood glucose sampling in fluoride tubes? An evidence-based study

Authors: Mohini Bhargava, Narinder Pal Singh, Anish Kumar Gupta

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2019

Login to get access

Excerpt

Blood glucose can be measured in serum or plasma. If serum is let to stand in contact with RBC, the glucose level falls due to the glycolytic process occurring in the cytoplasm of the RBC. Fluoride, which blocks the glycolysis cycle, is being used as an additive in blood glucose collection tubes for decades. The use of these tubes was suitable for blood collection when there was a long delay (4 h or more) in separation of serum following blood collection. Recently with the availability of gel serum separator tubes (SST), serum no longer remains in contact with RBC as soon as the specimen is centrifuged. We hypothesized that the use of fluoride tubes can be eliminated if the glucose levels in gel tubes and fluoride tubes show no significant difference within 1 to 2 h of centrifugation and then after separation from RBCs for up to at least 4 h. Earlier study has shown that glucose is stable for 48–72 h, when separated from the red cells [1]. Some studies have also reported that there was no difference in glucose values for blood samples collected in plain gel tubes and fluoride tubes that were separated within 2 h of collection [2, 3], but the sample size was a limitation for valid statistical inference. American Diabetes Association (ADA) no longer recommends the use of fluoride to control glycolysis [4]. …
Literature
1.
go back to reference Joseph R, Frederick W, Andrew M. The stability of glucose in serum. Clin Chem. 1963;9(3):356–9. Joseph R, Frederick W, Andrew M. The stability of glucose in serum. Clin Chem. 1963;9(3):356–9.
2.
go back to reference Fernandez L, Jee P, Klein MJ, Fischer P, Perkins SL, Brooks SP. A comparison of glucose concentration in paired specimens collected in serum separator and fluoride/potassium oxalate blood collection tubes under survey ‘field’ conditions. Clin Biochem. 2013;46(4–5):285–8.CrossRefPubMed Fernandez L, Jee P, Klein MJ, Fischer P, Perkins SL, Brooks SP. A comparison of glucose concentration in paired specimens collected in serum separator and fluoride/potassium oxalate blood collection tubes under survey ‘field’ conditions. Clin Biochem. 2013;46(4–5):285–8.CrossRefPubMed
3.
go back to reference Bruns DE. Are fluoride-containing blood tubes still needed for glucose testing? Clin Biochem. 2013;46(4–5):289–90.CrossRefPubMed Bruns DE. Are fluoride-containing blood tubes still needed for glucose testing? Clin Biochem. 2013;46(4–5):289–90.CrossRefPubMed
4.
go back to reference David BS, Mark A, George LB, David EB, Andrea RH, Kirkman MS, et al. Guidelines and recommendation for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):1–47.CrossRef David BS, Mark A, George LB, David EB, Andrea RH, Kirkman MS, et al. Guidelines and recommendation for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):1–47.CrossRef
Metadata
Title
Should we still collect blood glucose sampling in fluoride tubes? An evidence-based study
Authors
Mohini Bhargava
Narinder Pal Singh
Anish Kumar Gupta
Publication date
01-04-2019
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0688-0

Other articles of this Issue 2/2019

International Journal of Diabetes in Developing Countries 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine